Cingulate Inc. (CING) vs Fortress Biotech, Inc. (FBIO)
Cingulate Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Cingulate Inc. and Fortress Biotech, Inc. are of similar size ($76.0M and $73.6M). Cingulate Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 14 metrics below, Fortress Biotech, Inc. leads on 11 and Cingulate Inc. on 3.
Valuation
Profitability
| Metric | CING | FBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 65.59% | 65.16% |
| Operating margin | 0.00% | (42.61%) | 0.00% |
| Net margin | 0.00% | 150.98% | 0.00% |
| Free cash flow margin | 0.00% | 183.80% | 0.00% |
| Return on equity | (198.74%) | 84.91% | (57.72%) |
| Return on assets | (123.76%) | 43.38% | (49.22%) |
| Return on invested capital | 0.00% | (41.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack